The rising danger of Khasar in the European region, in case of infection at the highest level of 25 years

0
20
The rising danger of Khasar in the European region, in case of infection at the highest level of 25 years

According to a survey by UN agencies, more than 1.227 lakh cases were registered in the European region in 2021, which is a close number of cases in 2021. This is the maximum number of cases since 1997.

The Khasra is calculated in the most infectious viruses, which have a profound effect on the body’s immunity. Physical ability and memory may end for fighting infection, which causes the victim to become sensitive to other diseases.

Often seriously infected hospitalization and other complications, including pneumonia, water shortages, nausea, anecophilitis, can cause the patient’s death. Also, Khasra may have to face long -term health effects like blindness.

According to the World Health Organization, 1.5 lakh people are expected to die due to global Khusra, most of which have not been recovered, or have not been completely suspected of the vaccine of children under the age of five.

According to UN agencies, 1.5 million cases of global measurements were registered, which shows that the disease is a major health threat.

Congo has been informed about the transformation and death of the country located in the democratic republic, America and every region of the world.

According to data obtained by March 1, 2021, 5 deaths have been reported in 5 countries in Europe and Central Asia.

Bounce after Covid -10

In 2024, about one -third of the total cases of Khusra worldwide emerged in the European region.

In 1997, the infection was decreasing from 2.516 lakh cases and in the 2016, the number reached 5,9. However, there was a serious again in 2018 and 2019 and 89 thousand and 1.06 lakh cases were reported respectively.

During the Covid -19 epidemic, the infection of the infection was re -increased in 2023 and 2024 due to the reduction of immunization coverage. According to UN agencies, the vaccine rate in many countries has not returned to the level before the epidemic, which has increased the risk.

The virus is still regularly spread out of the border and where the vaccine coverage is not enough, there is the risk of spreading infectious diseases, especially for children.

Currently, about 40 percent of the total cases recorded in the European region have been reported about 40 percent of children. Infected people have to be admitted to the hospital in about 50 % of cases.

The most affected zone

According to the latest analysis, the maximum number of Romania in 2021 is in the case of 30 thousand 692 infections, followed by Kazakhstan.

Bosnia and Herzegovina, Montenegro, Northern Macedonia and Romania, less than 5 percent of children have got MCV 1 vaccine.

According to UN agencies, the vaccine coverage needs to be 95 percent to develop the combined immunity against this infection, but it is much less currently.

In some countries, this rate was close to 70 percent for the last five years.

Call for instant action

It is reported that in 2021, about five million children in the European region were not given the first suspect (MCV 1) to prevent the attack, which was covered under regular immunization services.

UNICEF warns that to protect children from this fatal disease, the governments of the countries need to take immediate action, which also has continuous investment in health care services.

Doctor Cluz says that in order to deal with these serious diseases, who is transformed into his regional health strategy, and no health protection will be achieved without a higher rate vaccine.

In this sequence, each country needs to reach those regions and population where there is no vaccine at adequate level.

UNICEF and those who are busy with the countries of the countries and their partner agencies to prevent the Khasra outbreak. Under this effort, health care workers are being trained, the vaccine program has been strengthened, the observation system is strengthened and Khasara immunization is being promoted where the vaccine rate is low.